HAEMONETICS CORP/MASS (HAE) Stock Cash Flow
NYSE:HAE - New York Stock Exchange, Inc. - US4050241003 - Common Stock
| TTM (2024-9-28) | 2024 (2024-3-30) | 2023 (2023-4-1) | 2022 (2022-4-2) | 2021 (2021-4-3) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 123.76M | 117.56M | 115.40M | 43.40M | 79.50M | |||
| Depreciation Amortization | 109.57M | 97.22M | 93.30M | 97.70M | 84.30M | |||
| Income Taxes - Deferred | N/A | -11.04M | 4.80M | 5.00M | -19.90M | |||
| Change In Working Capital | -166.92M | -74.70M | 25.50M | -15.20M | -59.70M | |||
| Interest Paid | N/A | 20.90M | 13.60M | 6.20M | 7.80M | |||
| Taxes Paid | N/A | 52.71M | 18.00M | 24.30M | 12.50M | |||
| Other non cash items | 35.76M | 52.72M | 34.10M | 41.30M | 24.60M | |||
| OPERATING CASH FLOW | 84.95M | 181.75M | 273.10M | 172.30M | 108.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -53.84M | -66.30M | -110.20M | -96.50M | -37.00M | |||
| Other Investing Activity | -390.71M | -256.09M | -33.60M | 10.20M | -388.40M | |||
| INVESTING CASH FLOW | -444.55M | -322.39M | -143.80M | -86.30M | -425.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 493.49M | 37.75M | -9.60M | -17.50M | 418.10M | |||
| Stock Issued/Repurchased | -67.33M | 7.21M | -68.00M | 6.50M | 10.20M | |||
| Other Financing Activity | -121.31M | -6.81M | -22.80M | -4.80M | -60.90M | |||
| FINANCING CASH FLOW | 304.85M | 38.16M | -100.40M | -15.70M | 367.50M | |||
| Exchange Rate Effect | 3.07M | -3.19M | -3.90M | -3.00M | 4.20M | |||
| CHANGE IN CASH | -51.68M | -105.67M | 25.00M | 67.30M | 55.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 84.95M | 181.75M | 273.10M | 172.30M | 108.80M | |||
| Capital Expenditure | -53.84M | -66.30M | -110.20M | -96.50M | -37.00M | |||
| FREE CASH FLOW | 31.11M | 115.45M | 162.90M | 75.80M | 71.80M | |||
All data in USD